Navigation Links
Eisai USA Foundation to Donate $1 Million to the Conquer Cancer Foundation of the American Society of Clinical Oncology
Date:5/9/2013

WOODCLIFF LAKE, N.J., May 9, 2013 /PRNewswire/ -- Eisai USA Foundation Inc., the charitable arm of Eisai Inc., announces that it has pledged a $1 million donation to the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO). The donation, which is being disbursed in four yearly installments of $250,000, will support the Conquer Cancer Foundation Mission Endowment, which was established to provide a long-term base of support to advance the Foundation's critical mission to improve the care and treatment of people living with cancer. The Mission Endowment focuses on funding research, professional education, patient education and information, international programs and initiatives that aim to improve access to and quality of care.

"Eisai USA Foundation is committed to advancing knowledge, research and patient care, particularly in oncology, a long-standing area of focus for Eisai," said Hideo Dan , executive vice president of the Eisai USA Foundation. "The work of the Conquer Cancer Foundation and ASCO aligns with our human health care (hhc) mission to help make a difference in the lives of patients. We are proud to support their vision of a world free from the fear of cancer."

"Eisai has been a dedicated supporter of the Conquer Cancer Foundation, providing critical funding for a range of initiatives over the years," said W. Charles Penley , MD, FASCO, Chair of the Conquer Cancer Foundation Board of Directors. "With Eisai's generous contribution to the Foundation's Mission Endowment, we can further expand our efforts to conquer cancer worldwide by funding breakthrough cancer research and sharing cutting-edge knowledge."

Eisai USA Foundation Inc.
The Eisai USA Foundation Inc. was established in 2008 as part of Eisai's commitment to be a responsible corporate citizen and contribute to the good of the society in which it does business. The Foundation focuses its charitable giving in four areas: health-related initiatives for patients and caregivers, disaster relief efforts, innovation in medical and pharmaceutical sciences, and community activities in the areas where Eisai's U.S. employees live and work.

Eisai Inc.
At Eisai Inc., human health care is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., our passionate commitment to patient care is the driving force behind our efforts to help address unmet medical needs. We are a fully integrated pharmaceutical business with discovery, clinical, manufacturing and marketing capabilities. Our key areas of commercial focus include oncology and specialty care (Alzheimer's disease, epilepsy and metabolic disorders). To learn more about Eisai Inc., please visit us at www.eisai.com/US

Eisai Inc. has affiliates that are part of a global product creation organization that includes R&D facilities in Massachusetts, New Jersey, North Carolina and Pennsylvania, as well as a global demand chain organization that includes manufacturing facilities in Maryland and North Carolina. Eisai's global areas of R&D focus include neuroscience; oncology; metabolic disorders; vascular, inflammatory and immunological reaction; and antibody-based programs.

Media Inquiries
Lisa Wolfe
201-746-2959
lisa_wolfe@eisai.com


'/>"/>
SOURCE Eisai Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Eisai To Sponsor 7th Annual National Walk For Epilepsy To Help Raise Epilepsy Awareness
2. Lynn Kramer, MD, Appointed Chief Clinical Officer of Eisai Product Creation Systems
3. FDA Grants Orphan Drug Status To Eisais Lenvatinib
4. Eisai Oncology to Present New Research on Eribulin at 35th Annual San Antonio Breast Cancer Symposium
5. Eisai USA Foundation to Donate $100,000 to the Hurricane Sandy New Jersey Relief Fund, $50,000 to the American Red Cross
6. Epilepsia Publishes Results From Two Studies Of Eisais Perampanel
7. Shaji Procida Appointed Vice President and Chief Financial Officer of Eisai Inc.
8. Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting
9. National Patient Advocate Foundations Annual Capitol Hill Briefing Focuses on Patient Access Barriers to Life-Saving Medicines Placed on Specialty Tiers by Commercial Insurance Plans and Medicare
10. Epilepsy Foundation To Present Epilepsy Therapy Project Lifetime Accelerator Award To Henrik Klitgaard, Ph.D., Recognizing Contributions To New Therapies
11. Cardinal Health Foundation Invites Local Non-profit Organizations To Apply For Grants To Prevent Prescription Drug Abuse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
(Date:6/23/2016)... June 23, 2016 , , ... July 7, 2016 , , , , LOCATION: , , ... , , , EXPERT PANELISTS:  , , , Frost & ... Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, ... The global pharmaceutical industry is witnessing an exceptional era. Several new ...
(Date:6/23/2016)... 2016 The vast majority of dialysis patients ... Treatments are usually 3 times a week, with treatment ... travel time, equipment preparation and wait time.  This regimen ... for patients who are elderly and frail.  Many elderly ... rehabilitation centers for some duration of time. ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy Eyeglasses, an ... United States and Canada wear eyeglasses. Once considered to be a purely functional part ... fashion statement. Even celebrities use glasses as a way of creating an iconic image—like ...
(Date:6/26/2016)... ... ... legally blind and certified personal trainer is helping to develop a weight loss fitness plan ... fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from PsychTests.com reveals that behind the tendency to ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
Breaking Medicine News(10 mins):